Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Biocartis Group NV (8XB.DU)

Dusseldorf - Dusseldorf Delayed Price. Currency in EUR
0.6990+0.0070 (+1.01%)
At close: 09:00PM CET
Advertisement
Advertisement
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
Total Revenue
52,778
48,269
43,128
37,444
Cost of Revenue
30,582
33,922
26,284
21,328
Gross Profit
22,196
14,347
16,844
16,116
Operating Expense
75,917
76,645
63,226
71,461
Operating Income
-53,721
-62,298
-46,382
-55,345
Net Non Operating Interest Income Expense
-8,967
-9,411
-15,768
-7,934
Pretax Income
-63,153
-71,715
-63,162
-64,167
Tax Provision
-190
-243
-228
-99
Net Income Common Stockholders
-62,963
-71,472
-62,934
-64,068
Diluted NI Available to Com Stockholders
-62,963
-71,472
-62,934
-64,068
Basic EPS
-
-1.06
-0.95
-0.97
Diluted EPS
-
-1.06
-0.95
-0.97
Basic Average Shares
-
67,477
66,381
65,752
Diluted Average Shares
-
67,477
66,381
65,752
Total Operating Income as Reported
-54,196
-62,645
-46,862
-55,602
Total Expenses
106,499
110,567
89,510
92,789
Net Income from Continuing & Discontinued Operation
-62,963
-71,472
-62,934
-64,068
Normalized Income
-62,487
-71,127
-62,456
-63,812
Interest Income
567
77
-
-
Interest Expense
9,410
9,320
10,184
7,099
Net Interest Income
-8,967
-9,411
-15,768
-7,934
EBIT
-53,743
-62,395
-52,978
-57,068
EBITDA
-43,409
-
-
-
Reconciled Cost of Revenue
30,582
33,922
26,284
21,328
Reconciled Depreciation
10,334
9,845
9,748
9,719
Net Income from Continuing Operation Net Minority Interest
-62,963
-71,472
-62,934
-64,068
Total Unusual Items Excluding Goodwill
-477
-346
-480
-256
Total Unusual Items
-477
-346
-480
-256
Normalized EBITDA
-42,932
-52,204
-42,750
-47,093
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
-1.4351
-1.1724
-1.7327
-0.395
Advertisement
Advertisement